Literature DB >> 32161483

Prevalence and Associated Factors of Metabolic Syndrome Among Patients with Severe Mental Illness at Hawassa, Southern-Ethiopia.

Tesfaye Teshome1, Dejene Hailu Kassa2, Agete Tadewos Hirigo3.   

Abstract

BACKGROUND: Patients with severe mental disorders have a high risk of metabolic-related complications like metabolic syndrome (MetS), diabetes mellitus (DM), hypertension and lipid derangements, and these factors may predispose them to a high mortality rate. Data is very scarce regarding MetS among patients with severe mental illness in Ethiopia. Therefore, this study aimed to assess the prevalence of MetS and its associated factors among patients with severe mental illness.
METHODS: A cross-sectional study was conducted in Hawassa University Comprehensive Specialized Hospital from January to June 2019 among adult patients attending a psychiatric outpatient department, Southern Ethiopia. A systematic random sampling technique was used to select 245 study subjects. Socio-demographic and other data were collected using a structured questionnaire. Both the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) and International Diabetes Federation (IDF) guidelines were used to define MetS.
RESULTS: The prevalence of MetS was 24.5% and 26.9% by NCEP-ATP and IDF criteria respectively. In both definitions, females had significantly higher MetS when compared to males (31.4% vs 19.6%; p=0.03 by NCEP), and (34.3% vs 21.7%; p =0.03 by IDF), respectively. Duration >5 years with mental illness indicated higher MetS when compared to duration ≤ 5 years (42.9% vs 19.9%, p=0.001; and 46.9% vs 21.9%, p<0.0001) in NCEP and IDF, respectively. In addition, marital status [AOR (95% CI): 2.4 (1.1-5.3)], and BMI [AOR (95% CI): 8.4(4.0-17.6)], duration > 5 years with mental illness [AOR (95% CI): 2.8(1.2-6.5)], and age >40 years [AOR (95% CI): 2.7(1.2-6.1)] were significantly associated factors of MetS by NCEP. While BMI, age >40 years and duration > 5 years with mental illness were associated with MetS by IDF.
CONCLUSION: Long-time experience with severe mental illness and antipsychotic therapy might predispose patients to metabolic complications with significant risks of cardiovascular events. Therefore, intensive screening of patients for MetS/components is required during follow-up based on national non-communicable diseases guideline. Besides, the proper intervention of patients concerning lifestyle changes and averting risk full behaviors is mandatory.
© 2020 Teshome et al.

Entities:  

Keywords:  Hawassa; Southern-Ethiopia; antipsychotic agents; metabolic syndrome; severe mental illness

Year:  2020        PMID: 32161483      PMCID: PMC7051251          DOI: 10.2147/DMSO.S235379

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  33 in total

1.  The poor physical health of people with mental illness.

Authors:  D P Osborn
Journal:  West J Med       Date:  2001-11

2.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 3.  Determinants of quality of life in people with severe mental illness.

Authors:  L Hansson
Journal:  Acta Psychiatr Scand Suppl       Date:  2006

4.  Association of the metabolic syndrome with depression and anxiety in Japanese men: a 1-year cohort study.

Authors:  Takeaki Takeuchi; Mutsuhiro Nakao; Kyoko Nomura; Mariko Inoue; Shinobu Tsurugano; Yasuko Shinozaki; Eiji Yano
Journal:  Diabetes Metab Res Rev       Date:  2009-11       Impact factor: 4.876

5.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

Review 6.  Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults.

Authors: 
Journal:  Arch Intern Med       Date:  1998-09-28

7.  Too many chronic mentally disabled patients are too fat.

Authors:  A K Gopalaswamy; R Morgan
Journal:  Acta Psychiatr Scand       Date:  1985-09       Impact factor: 6.392

8.  Prevalence of Metabolic Syndrome among Working Adults in Ethiopia.

Authors:  A Tran; B Gelaye; B Girma; S Lemma; Y Berhane; T Bekele; A Khali; M A Williams
Journal:  Int J Hypertens       Date:  2011-05-26       Impact factor: 2.420

9.  Metabolic syndrome and psychiatric disorders: a population-based study.

Authors:  Fernanda Pedrotti Moreira; Karen Jansen; Taiane de A Cardoso; Thaíse C Mondin; Pedro V Magalhães; Flavio Kapczinski; Luciano D M Souza; Ricardo A da Silva; Jean Pierre Oses; Carolina D Wiener
Journal:  Braz J Psychiatry       Date:  2018-10-11       Impact factor: 2.697

10.  Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics.

Authors:  Antonio Ventriglio; Ross J Baldessarini; Giovanna Vitrani; Iris Bonfitto; Angela Chiara Cecere; Angelo Rinaldi; Annamaria Petito; Antonello Bellomo
Journal:  Front Psychiatry       Date:  2019-01-16       Impact factor: 4.157

View more
  5 in total

Review 1.  Metabolic syndrome among people with mental illness in sub Saharan Africa: Female gender as a factor. A Systematic review and meta-analysis.

Authors:  Robel Hussen Kabthymer; Solomon Nega Techane; Solomon Hailemariam; Yibeltal Alemu Bekele; Birhanie Mekuriaw
Journal:  Ann Med Surg (Lond)       Date:  2021-04-30

2.  The Prevalence of Metabolic Syndrome in Ethiopian Population: A Systematic Review and Meta-analysis.

Authors:  Sintayehu Ambachew; Aklilu Endalamaw; Abebaw Worede; Yalewayker Tegegne; Mulugeta Melku; Belete Biadgo
Journal:  J Obes       Date:  2020-12-16

3.  Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia.

Authors:  Feyissa Challa; Tigist Getahun; Meron Sileshi; Zeleke Geto; Teshome S Kelkile; Sintayehu Gurmessa; Girmay Medhin; Miraf Mesfin; Melkam Alemayehu; Tigist Shumet; Anwar Mulugeta; Desalegn Bekele; Christina P C Borba; Claire E Oppenheim; David C Henderson; Abebaw Fekadu; Anna Carobene; Solomon Teferra
Journal:  BMC Psychiatry       Date:  2021-12-11       Impact factor: 3.630

4.  Prevalence of central obesity and associated factors in Ethiopia: A systematic review and meta-analysis.

Authors:  Kirubel Dagnaw Tegegne; Gebeyaw Biset Wagaw; Natnael Atnafu Gebeyehu; Lehulu Tilahun Yirdaw; Nathan Estifanos Shewangashaw; Nigusie Abebaw Mekonen; Mesfin Wudu Kassaw
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-30       Impact factor: 6.055

Review 5.  Metabolic syndrome and its associated factors in Ethiopia: A systematic review and meta-analysis.

Authors:  Tadeg Jemere; Belayneh Kefale
Journal:  J Diabetes Metab Disord       Date:  2021-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.